why choose us

First received: March 22, 2023

Clinical Trial: Using BCG Vaccine to Understand Tuberculosis Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tuberculosis

Study Type: INTERVENTIONAL


Official Title: A Feasibility Study of Controlled Human Infection With Intradermal Bacillus Calmette-Guérin Injection

Brief Summary: Tuberculosis (TB) is a disease that usually causes an infection in the lungs.The only vaccine to prevent TB is called BCG (Bacillus Calmette-Guérin).BCG contains a live germ similar to Mycobacterium tuberculosis, the germ that causes TB.BCG does not work very well, and TB remains the most common cause of death by infection worldwide.Human challenge models involve exposing healthy volunteers to an infectious disease in a safe and controlled way.This helps researchers understand more about an infectious disease and…

Read more